CHEMOTHERAPY OF COLORECTAL-CANCER

被引:26
作者
BLIJHAM, GH
机构
关键词
CHEMOTHERAPY; COLORECTAL CANCER; 5-FU;
D O I
10.1097/00001813-199106000-00003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Advanced colorectal cancer belongs to the most chemotherapy-resistant human malignancies. The cytotoxic agent with the most consistent antitumor activity has been 5-fluorouracil (5-FU). With this drug, response rates vary between 15% (with conventional weekly or 5-day bolus injection) and 30% (with continuous infusions of 24 h to 12 weeks); survival advantages of the latter approach have not been demonstrated. Combinations of 5-FU with other cytotoxic agents with some activity have been found unsuccessful. Because of its complex metabolism the efficacy-toxicity ratio of 5-FU can be positively influenced by biochemical modulation with agents leading to decrecreased availability of competing substrates, increased availability of co-substrates or more efficient interactions with target substances. Superior response rates (20-40%) have been observed upon the addition of leucovorin methotrexate and N-(phosphonacetyl)-L-aspartic acid; survival was modestly prolonged (2-3 months) in two leucovorin and one methotrexate study. Interferon-alpha, inactive as a single agent, appears to synergize with 5-FU at the cost of considerable toxicity; results from randomized trials of this combination are awaited. 5-FU has also been the mainstay of adjuvant treatments; in poor-prognosis rectal cancer it appears to improve survival if added to radiotherapy, whereas in combination with levamisol the survival of node-positive colonic carcinoma patients can be prolonged.
引用
收藏
页码:233 / 245
页数:13
相关论文
共 135 条
  • [61] 2-5
  • [62] JOHNSON RK, 1980, P AM ASSOC CANC RES, V21, P292
  • [63] KAPLAN RS, 1982, SEMIN ONCOL, V9, P103
  • [64] KEMENY N, 1990, CANCER, V66, P2470, DOI 10.1002/1097-0142(19901215)66:12<2470::AID-CNCR2820661205>3.0.CO
  • [65] 2-Y
  • [66] RANDOMIZED STUDY OF CONTINUOUS INFUSION FLUOROURACIL VERSUS FLUOROURACIL PLUS CISPLATIN IN PATIENTS WITH METASTATIC COLORECTAL-CANCER
    KEMENY, N
    ISRAEL, K
    NIEDZWIECKI, D
    CHAPMAN, D
    BOTET, J
    MINSKY, B
    VINCIGUERRA, V
    ROSENBLUTH, R
    BOSSELLI, B
    COCHRAN, C
    SHEEHAN, K
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (02) : 313 - 318
  • [67] INTRAHEPATIC OR SYSTEMIC INFUSION OF FLUORODEOXYURIDINE IN PATIENTS WITH LIVER METASTASES FROM COLORECTAL-CARCINOMA - A RANDOMIZED TRIAL
    KEMENY, N
    DALY, J
    REICHMAN, B
    GELLER, N
    BOTET, J
    ODERMAN, P
    [J]. ANNALS OF INTERNAL MEDICINE, 1987, 107 (04) : 459 - 465
  • [68] KEMENY N, 1983, CANCER, V51, P20, DOI 10.1002/1097-0142(19830101)51:1<20::AID-CNCR2820510106>3.0.CO
  • [69] 2-D
  • [70] ROLE OF CHEMOTHERAPY IN THE TREATMENT OF COLORECTAL-CARCINOMA
    KEMENY, N
    [J]. SEMINARS IN SURGICAL ONCOLOGY, 1987, 3 (03): : 190 - 214